Emtricitabine and Tenofovir Disoproxil Fumarate

Product NDC
59651-166
11-digit product format
596510166
Labeler code
59651
Product ID
59651-166_a805c27a-1154-4aac-9af8-bbd755be027f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Emtricitabine and Tenofovir Disoproxil Fumarate
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA211640
Marketing category
ANDA
Marketing start
2023-03-09
Substance
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active strength
133; 200 mg/1; mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
G70B4ETF4SEMTRICITABINE143491-57-0EMTRICITABINE
OTT9J7900ITENOFOVIR DISOPROXIL FUMARATE202138-50-9TENOFOVIR DISOPROXIL FUMARATE

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
59651-166-305965101663030 TABLET, FILM COATED in 1 BOTTLE (59651-166-30) 2023-03-09NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Emtricitabine and Tenofovir Disoproxil FumarateAurobindo Pharma Limited2024-01-03Human Prescription Drug Label2